Last Updated: 01/15/2016 00:56:04
NCZ Stock Chart - 1 Month
NCZ Stock Chart - 3 Month
NCZ Stock Chart - 6 Month
NCZ Stock Chart - 1 Year
NCZ Stock Chart - 2 Year
Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....
Continue Reading
They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...
Continue Reading
A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...
Continue Reading
Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...
Continue Reading
Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...
Continue Reading
Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...
Continue Reading
Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...
Continue Reading
Financial Overview of Zepp Health Corporation's Third Quarter Zepp Health Corporation (NYSE: ZEPP) recently released its unaudited financial results for the third quarter. The company's revenues totaled $42.5 million with a basic and diluted net loss per share recorded at $0.05, translating to a net loss of $13.3 million. Notably, these figures reflect a challenge the...
Continue Reading
Artea Bank Launches New Fund for Multi-Apartment Building Renovations AB Artea Bankas has announced its intention to establish a third fund aimed at modernizing multi-apartment buildings. This initiative follows a notification from the European Investment Bank (EIB), signaling the start of negotiations for this new venture. Projected assets for the fund are substantial,...
Continue Reading
Expected Earnings Report for PROCEPT BioRobotics PROCEPT BioRobotics (NASDAQ: PRCT) has set the stage for its next quarterly earnings report, which is eagerly anticipated by investors. The earnings release is scheduled for an upcoming Monday, an event that this company looks forward to with optimism. Market analysts currently predict that PROCEPT BioRobotics will post an...
Continue Reading
Akebia Unveils New Public Offering of Common Stock Akebia Therapeutics, Inc. (Nasdaq: AKBA), a dedicated biopharmaceutical company focused on improving the lives of individuals affected by kidney disease, has publicly announced the pricing details of its recent offering. This offering involves 25 million shares of common stock, each priced at $2.00, aiming to generate...
Continue Reading
Crédit Agricole SA Adjusts Liquidity Contract with Kepler Cheuvreux In a significant move, Crédit Agricole S.A. has announced a reduction of resources available for its liquidity contract with Kepler Cheuvreux. This shift aims to enhance the market activity surrounding the shares of the company, providing better stability and trading conditions in the financial market....
Continue Reading